Jolanta Brankiewicz, APRN
Family · Wolcott, CTNPI 1629581525
Payments from drug & device makers
Across 607 payments — averaging $20.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$3K
- AbbVie$2K
- Novo Nordisk$2K
- Boston Scientific$875
- Amarin Pharma, Inc.$847
- AstraZeneca$476
- plus $4K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 138 | $3,197 |
| AbbVie | 97 | $1,701 |
| Novo Nordisk | 104 | $1,690 |
| Boston Scientific | 46 | $875 |
| Amarin Pharma, Inc. | 48 | $847 |
| AstraZeneca | 18 | $476 |
| Amgen | 20 | $435 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $400 |
| GSK | 15 | $364 |
| Antares Pharma, Inc. | 14 | $290 |
| Merck | 13 | $279 |
| Exact Sciences | 8 | $219 |
| Abbott | 9 | $213 |
| Lilly USA, LLC | 9 | $206 |
| Halozyme Inc | 4 | $173 |
| Astellas Pharma US Inc | 12 | $169 |
| Boehringer Ingelheim | 6 | $134 |
| Biohaven Pharmaceuticals, Inc. | 1 | $116 |
| Idorsia Pharmaceuticals US Inc | 4 | $71 |
| Pfizer | 3 | $70 |
| Sanofi-aventis U.S. LLC | 3 | $70 |
| Lundbeck LLC | 3 | $63 |
| Dexcom, Inc. | 3 | $59 |
| Johnson & Johnson | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Viatris Specialty LLC | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
How this compares
$12,333 in reported general payments places this provider in the 95th percentile of 1,596 family providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Wolcott
- Elisha ChristiansonWaterbury$371K
- Kathryn TierneyNew Britain$140K
- Jennifer SilvaSouth Windsor$91K
- Carli WillardEnfield$74K
- Erin MartinMilford$70K
- Dayna GiordanoNew Haven$65K
- Diana BytyqiDerby$53K
- Farhiya AbdiSouth Windsor$30K
- Nicole SandilandsBridgeport$30K
- Ralph HirschfeldPutnam$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.